Zdrowie i gospodarka · 28/12/2022
FDA Classifies Interventional Cardiovascular Implant Simulation Software Device into Class II with Special Controls
The FDA has classified the interventional cardiovascular implant simulation software device into Class II with special controls, aiming to ensure safety and effectiveness while enhancing patients' access to innovative devices.
Source: Federal Register — Food and Drug AdministrationOpen original release →